ABSTRACT
OBJECTIVE: After a HGSIL cervical smear, to appraise the diagnostic and treatment modalities by comparing with national recommendations. STUDY DESIGN: A clinical audit concerning 444 women with a HGSIL cervical smear, within the first 3 years of the programme. RESULTS: Among the 413 women followed-up (98%), the colposcopy rate reached 71% at 3 months and 81% at 1 year. It was lower for women who had a history of other abnormal Pap smears than for those with no gynaecological symptoms or past history (66% versus 87%, P = 0.02), it was higher when the cytology report showed a CIN III than when a CIN II was reported (84% versus 78%, P = 9 x 10(-4). After the colposcopy, 23 women (7%) were lost to follow-up. Among the 76 women without a colposcopy, 17 (22%) did not have any histological examinations during their follow-up. CONCLUSION: Measures to improve women's follow-up compliance and ensure appropriate physician behaviours are necessary to achieve better quality in this screening programme.
